False advertising and deceptive promotion can have deadly consequences. But big pharma appears to be acting outside the law, no matter the costs. That appears to be the case with manufacturers of the antidepressants Lexapro and Paxil.Mothers of babies born with birth defects have filed numerous lawsuits against Forest Labs, manufacturer of Lexapro, for failure to warn them of potential risks to their unborn babies. Meanwhile, class action lawsuits against Paxil parent company GlaxoSmithKline have already cost the company billions of dollars in compensation. Yet, research shows both companies were aware of problems with their products, but chose to keep the information concealed or failed to issue proper warnings.
Big pharma’s assault on the most vulnerable victims
The dangers of Lexapro are well documented. The chemicals it contains can travel through the placenta, putting both unborn baby and mother at risk for serious complications, even death.